MarketsStocksTATVA
TA

Tatva Chintan Pharma Chem Ltd

NSE: TATVABSE: 543321Chemicals
Download Research Report7-page PDF
1,145.20
-3.24%
NSE · auto-updates while market open
Prev Close
₹932.75
Day High
₹1,179.90
Day Low
₹1,131.90
Mkt Cap
₹2,607 Cr
P / E
62.0
P / B
3.3
ROE
5.5%
52W High
₹1,610.00
52W Low
₹886.00
Key Metrics
Market Cap
₹2,607 Cr
P / E
62.00
P / B
3.33
EV / EBITDA
30.92
ROCE
7.1%
ROE
5.5%
Debt / Equity
0.15
Book Value
₹334.20
EPS
₹17.98
Div Yield
0.1%
Face Value
₹10
Promoter Holding
72.0%
Revenue · ₹ Cr
434
FY22
424
FY23
394
FY24
383
FY25
506
FY26
Net Profit · ₹ Cr
96
FY22
45
FY23
30
FY24
6
FY25
42
FY26
EPS · ₹ per share
₹44.6
FY22
₹20.5
FY23
₹13.3
FY24
₹2.4
FY25
₹18.0
FY26
P / E Ratio · price ÷ TTM EPS
1115229443551240-4Mar 22Aug 23Jan 25Jun 26
P/E 63.4×Median 87.3×TTM EPS
Q1 2026 snapshot
Sales
₹134 Cr
Operating profit
-
OPM
-
Net profit
₹10 Cr
EPS
₹4.41
Scorecard · 7 axes
Quality
Weak
42/100
Valuation
Bad
62.0×
Growth
Bad
-7.3%
Profitability
Weak
6.3%
Performance
Good
+26.6%
Entry Point
Good
71%
Red Flags
Strong
0 flags
Shareholding Pattern
72.0%Promoter
Promoter72.0%
FII3.8%
DII3.0%
Public21.2%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue85.896108.59118.02124.52133.07133.8
Net Profit0.1381.036.6519.91715.16510.321
NPM %0.2%0.9%5.6%8.0%11.4%7.7%
AlertPre-trade